Etzer Darout Analyst PerformanceAnalyst at BarclaysEtzer Darout is a stock analyst at Barclays focused in the medical sector, covering 36 publicly traded companies. Over the past year, Etzer Darout has issued 140 stock ratings, including strong buy, buy, hold, and sell recommendations. While full access to Etzer Darout's proprietary MarketBeat Analyst Ranking is reserved for MarketBeat All Access subscribers, the rating is updated daily to reflect the most recent analyst activity. This profile highlights Etzer Darout's coverage history, rating activity, and performance tendencies — helping individual investors make more informed trading decisions. Analyst Rankings, Coverage, and Performance StatisticsAnalyst RankingSubscribe to MarketBeat All Access for the analyst's recommendation accuracy rating MarketBeatAverage Return00.00% 12-Month ROISuccess Rate00.00% Profitable RatingsTotal Ratings159 Last 6 YearsBuy Recommendations82.05% 128 Buy RatingsCompanies Covered36 Unique Companies Ratings Distribution156RatingsDistribution of strong buy, buy, hold, and sell ratings by Etzer Darout.RatingPercentageCount Strong Buy1.9%3 ratings Buy80.1%125 ratings Hold12.2%19 ratings Sell5.8%9 ratingsOut of 156 total stock ratings issued by Etzer Darout at Barclays, the majority (80.1%) have been Buy recommendations, followed by 12.2% Hold, 5.8% Sell, and 1.9% Strong Buy.Best & Worst CallsBest Call000.0%IVAApr 2025Subscribe to MarketBeat All Access to get analyst recommendation ROI.Worst Call000.0%ARVNFeb 2025Subscribe to MarketBeat All Access to get analyst recommendation ROI.Exchange CoverageExchangePercentageCountNASDAQ100.0% of companies on NASDAQ36 companiesEtzer Darout, an analyst at Barclays, currently covers 36 companies listed on , with the majority traded on NASDAQ.Coverage FocusSector IconSectorPercentageMedical35 companies97.2%Manufacturing1 company2.8%Etzer Darout of Barclays specializes in stock coverage within the Medical sector, with additional focus on Manufacturing companies.Coverage IndustriesIndustryPercentageMED - BIOMED/GENE28 companies77.8%MED - DRUGS5 companies13.9%BIOTECHNOLOGY1 company2.8%MED PRODUCTS1 company2.8%PHARMACEUTICAL PREPARATIONS1 company2.8% Etzer Darout's Ratings History at Barclays Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 4 Years 5 Years All Time Timeframe Start Date End Date All Ratings Strong Buy Buy Hold Sell Rating Recommendation ROI is the percentage between the price on the Report Date to the price 12 months after the report date.Available with a MarketBeat All Access Subscription12-Month ROIUpgrade to All Access to use the All ROI Filter Export CompanyReport DateActionReport Date Price12-MonthPrice TargetRating12-MonthPrice & ROIDetailsTRAXFirst Tracks Biotherapeutics7/21/2026Boost Price Target$36.87$48.00Overweight$0.0000.00% ROIFBRXForte Biosciences7/21/2026Initiated Coverage$47.49$74.00Overweight$0.0000.00% ROIFBRXForte Biosciences7/21/2026Initiated Coverage$50.73$74.00Overweight$0.0000.00% ROIPTGXProtagonist Therapeutics7/14/2026Boost Price Target$129.89$151.00Overweight$0.0000.00% ROIJAZZJazz Pharmaceuticals7/14/2026Boost Price Target$236.97$260.00Overweight$0.0000.00% ROIINCYIncyte7/14/2026Boost Price Target$114.23$134.00Overweight$0.0000.00% ROIEXELExelixis7/14/2026Boost Price Target$56.04$49.00Equal Weight$0.0000.00% ROINUVLNuvalent6/9/2026Reiterated Rating$123.24$124.00Equal Weight$0.0000.00% ROINUVLNuvalent6/9/2026Downgrade$123.35Hold$0.0000.00% ROIJAZZJazz Pharmaceuticals5/27/2026Boost Price Target$237.41$253.00Overweight$0.0000.00% ROI Get the Latest News and Ratings for Your StocksEnter your email address below to receive the latest headlines and analysts' recommendations for your stocks with our free daily email newsletter. RLAYRelay Therapeutics5/20/2026Boost Price Target$12.07$27.00Overweight$0.0000.00% ROIARVNArvinas5/13/2026Boost Price Target$9.57$20.00Overweight$0.0000.00% ROIANABAnaptysBio5/13/2026Boost Price Target$65.58$75.00Overweight$0.0000.00% ROISRRKScholar Rock5/8/2026Boost Price Target$46.45$55.00Overweight$0.0000.00% ROICLDXCelldex Therapeutics5/8/2026Boost Price Target$33.05$48.00Overweight$0.0000.00% ROIJAZZJazz Pharmaceuticals5/6/2026Boost Price Target$212.26$234.00Overweight$0.0000.00% ROISNDXSyndax Pharmaceuticals5/1/2026Boost Price Target$19.86$37.00Overweight$0.0000.00% ROIORKAOruka Therapeutics4/27/2026Boost Price Target$82.33$160.00Overweight$0.0000.00% ROITRAXFirst Tracks Biotherapeutics4/22/2026Initiated Coverage$17.00$40.00Overweight$0.0000.00% ROIANABAnaptysBio4/22/2026Lower Price Target$51.82$63.00Overweight$0.0000.00% ROIMGNXMacroGenics4/20/2026Boost Price Target$3.46$6.00Overweight$0.0000.00% ROIJAZZJazz Pharmaceuticals4/20/2026Boost Price Target$203.42$225.00Overweight$0.0000.00% ROIEXELExelixis4/20/2026Boost Price Target$44.89$45.00Equal Weight$0.0000.00% ROIJANXJanux Therapeutics4/20/2026Downgrade$15.82$14.00Underweight$0.0000.00% ROICLDXCelldex Therapeutics4/20/2026Upgrade$34.55$45.00Overweight$0.0000.00% ROIRLAYRelay Therapeutics4/8/2026Boost Price Target$14.23$21.00Overweight$0.0000.00% ROIORKAOruka Therapeutics4/7/2026Boost Price Target$58.94$78.00Overweight$0.0000.00% ROITERNTerns Pharmaceuticals3/30/2026Reiterated Rating$52.87$53.00Equal Weight$0.0000.00% ROITERNTerns Pharmaceuticals3/27/2026Downgrade$52.88Hold$0.0000.00% ROIABVXAbivax3/24/2026Boost Price Target$115.07$148.00Overweight$0.0000.00% ROIPTGXProtagonist Therapeutics3/19/2026Boost Price Target$102.06$119.00Overweight$0.0000.00% ROICTMXCytomX Therapeutics3/19/2026Boost Price Target$4.86$16.00Overweight$0.0000.00% ROIORKAOruka Therapeutics3/13/2026Boost Price Target$39.79$50.00Overweight$0.0000.00% ROIBNTXBioNTech3/11/2026Lower Price Target$91.57$128.00Outperform$0.0000.00% ROIMGNXMacroGenics3/10/2026Boost Price Target$2.93$4.00Overweight$0.0000.00% ROIJAZZJazz Pharmaceuticals3/9/2026Reiterated Rating$185.40$224.00Overweight$0.0000.00% ROIANABAnaptysBio3/4/2026Boost Price Target$56.22$79.00Overweight$0.0000.00% ROISRRKScholar Rock3/4/2026Boost Price Target$45.78$70.00Outperform$0.0000.00% ROISRRKScholar Rock3/3/2026Boost Price Target$44.31$53.00Overweight$0.0000.00% ROIJAZZJazz Pharmaceuticals2/27/2026Initiated Coverage$188.97$224.00Overweight$0.0000.00% ROITicker Revealed: Pre-IPO Access to "Next Elon Musk" Company (Ad)We’ve found The Next Elon Musk… and what we believe to be the next Tesla. It’s already racked up $26 billion in government contracts. Peter Thiel just bet $1 Billion on it.👉 Unlock the ticker now and get it completely free.CCCCC4 Therapeutics2/26/2026Boost Price Target$2.75$7.00Overweight$0.0000.00% ROIXNCRXencor2/26/2026Boost Price Target$13.37$27.00Overweight$0.0000.00% ROIPTGXProtagonist Therapeutics2/26/2026Boost Price Target$86.70$113.00Overweight$0.0000.00% ROIIOVAIovance Biotherapeutics2/25/2026Boost Price Target$4.27$11.00Overweight$0.0000.00% ROIVIRVir Biotechnology2/24/2026Boost Price Target$9.50$30.00Overweight$0.0000.00% ROIINCYIncyte2/18/2026Boost Price Target$101.16$117.00Overweight$0.0000.00% ROIVIRVir Biotechnology2/17/2026Set Price Target$7.47$26.00$0.0000.00% ROIVIRVir Biotechnology2/4/2026Reiterated Rating$7.68$24.00Overweight$0.0000.00% ROIINCYIncyte2/4/2026Boost Price Target$100.92$116.00Overweight$0.0000.00% ROIEXELExelixis2/4/2026Boost Price Target$42.59$44.00Equal Weight$0.0000.00% ROICTMXCytomX Therapeutics2/4/2026Boost Price Target$6.07$10.00Overweight$0.0000.00% ROIRAPTRapt Therapeutics1/21/2026Downgrade$57.61$58.00Equal Weight$0.0000.00% ROICRVSCorvus Pharmaceuticals1/20/2026Boost Price Target$21.43$28.00Overweight$0.0000.00% ROICTMXCytomX Therapeutics1/20/2026Boost Price Target$5.39$8.00Overweight$0.0000.00% ROIANABAnaptysBio1/20/2026Boost Price Target$45.68$78.00Overweight$0.0000.00% ROIXNCRXencor12/17/2025Boost Price Target$16.55$26.00Overweight$0.0000.00% ROISRRKScholar Rock12/17/2025Boost Price Target$44.32$52.00Overweight$0.0000.00% ROIPTGXProtagonist Therapeutics12/17/2025Boost Price Target$91.54$108.00Overweight$0.0000.00% ROIJANXJanux Therapeutics12/17/2025Lower Price Target$14.65$29.00Overweight$0.0000.00% ROIIOVAIovance Biotherapeutics12/17/2025Boost Price Target$2.25$10.00Overweight$0.0000.00% ROICCCCC4 Therapeutics12/17/2025Lower Price Target$2.26$5.00Overweight$0.0000.00% ROIARVNArvinas12/17/2025Boost Price Target$11.90$18.00Overweight$0.0000.00% ROIANABAnaptysBio12/17/2025Lower Price Target$45.03$55.00Overweight$0.0000.00% ROISMMTSummit Therapeutics12/17/2025Set Price Target$17.23$18.00$0.0000.00% ROISMMTSummit Therapeutics12/17/2025Upgrade$17.23$18.00Equal Weight$0.0000.00% ROICLDXCelldex Therapeutics12/17/2025Boost Price Target$26.61$24.00Underweight$0.0000.00% ROIIOVAIovance Biotherapeutics12/17/2025Boost Price Target$2.82$10.00Overweight$0.0000.00% ROITERNTerns Pharmaceuticals12/9/2025Boost Price Target$40.23$56.00Overweight$0.0000.00% ROIKYMRKymera Therapeutics12/9/2025Boost Price Target$94.30$119.00Overweight$0.0000.00% ROITERNTerns Pharmaceuticals11/25/2025Boost Price Target$28.04$36.00Overweight$0.0000.00% ROIKURAKura Oncology11/24/2025Reiterated Rating$11.17$28.00Overweight$0.0000.00% ROIIOVAIovance Biotherapeutics11/24/2025Boost Price Target$2.24$9.00Overweight$0.0000.00% ROISNDXSyndax Pharmaceuticals11/24/2025Boost Price Target$18.44$35.00Overweight$0.0000.00% ROINUVLNuvalent11/17/2025Set Price Target$108.00$152.00$0.0000.00% ROISRRKScholar Rock11/17/2025Boost Price Target$36.58$45.00Overweight$0.0000.00% ROISRRKScholar Rock11/14/2025Reiterated Rating$37.47$50.00Outperform$0.0000.00% ROITERNTerns Pharmaceuticals11/11/2025Boost Price Target$19.12$28.00Overweight$0.0000.00% ROIANABAnaptysBio11/11/2025Lower Price Target$33.98$70.00Overweight$0.0000.00% ROICLDXCelldex Therapeutics11/11/2025Lower Price Target$22.98$21.00Underweight$0.0000.00% ROIRAPTRapt Therapeutics11/7/2025Lower Price Target$28.60$56.00Overweight$0.0000.00% ROIPTGXProtagonist Therapeutics11/7/2025Boost Price Target$78.49$88.00Overweight$0.0000.00% ROIJANXJanux Therapeutics11/7/2025Boost Price Target$25.63$48.00Overweight$0.0000.00% ROIARVNArvinas11/6/2025Boost Price Target$9.82$16.00Overweight$0.0000.00% ROIKYMRKymera Therapeutics11/5/2025Boost Price Target$59.91$70.00Overweight$0.0000.00% ROIEXELExelixis11/5/2025Boost Price Target$37.90$41.00Equal Weight$0.0000.00% ROITERNTerns Pharmaceuticals11/4/2025Boost Price Target$14.03$27.00Overweight$0.0000.00% ROIXNCRXencor10/29/2025Upgrade$14.25$23.00Overweight$0.0000.00% ROIXNCRXencor10/29/2025Upgrade$14.25$23.00Overweight$0.0000.00% ROITERNTerns Pharmaceuticals10/22/2025Lower Price Target$7.61$14.00Overweight$0.0000.00% ROISMMTSummit Therapeutics10/21/2025Boost Price Target$20.03$16.00Underweight$0.0000.00% ROITrump Takes Emergency Action - Plus Elon Musk's New Venture (Ad)Elon Musk has quietly launched a new venture - one that has nothing to do with rockets, EVs, or Neuralink. Trump has issued emergency support to accelerate the rollout, and it's already live in multiple states. The Financial Times reports Sam Altman is personally calling people to build this for OpenAI. A few little-known companies control the entire supply chain - meaning anyone who wants access must go through them. Their stocks are available to buy right now.See which companies control the supply chain behind this emerging techCTMXCytomX Therapeutics10/21/2025Boost Price Target$3.74$6.00Overweight$0.0000.00% ROIRAPTRapt Therapeutics10/21/2025Boost Price Target$33.67$58.00Overweight$0.0000.00% ROITVRDTvardi Therapeutics10/13/2025Set Price Target$6.69$5.00Equal Weight$0.0000.00% ROITVRDTvardi Therapeutics10/13/2025Initiated Coverage$41.60$61.00Overweight$0.0000.00% ROIRAPTRapt Therapeutics10/13/2025Set Price Target$26.79$35.00Overweight$0.0000.00% ROIORKAOruka Therapeutics10/13/2025Initiated Coverage$24.49$48.00Overweight$0.0000.00% ROIMNPRMonopar Therapeutics10/13/2025Set Price Target$87.82$125.00Overweight$0.0000.00% ROICRVSCorvus Pharmaceuticals10/13/2025Initiated Coverage$6.93$16.00Overweight$0.0000.00% ROIANABAnaptysBio10/13/2025Initiated Coverage$31.37$78.00Overweight$0.0000.00% ROIABVXAbivax10/13/2025Initiated Coverage$93.77$142.00Overweight$0.0000.00% ROICLDXCelldex Therapeutics10/13/2025Initiated Coverage$26.77$25.00Underweight$0.0000.00% ROIABVXAbivax10/13/2025Initiated Coverage$95.63$142.00Overweight$0.0000.00% ROIANABAnaptysBio10/13/2025Initiated Coverage$32.46$78.00Overweight$0.0000.00% ROICRVSCorvus Pharmaceuticals10/13/2025Initiated Coverage$7.11$16.00Overweight$0.0000.00% ROIMNPRMonopar Therapeutics10/13/2025Initiated Coverage$102.05$125.00Overweight$0.0000.00% ROIORKAOruka Therapeutics10/13/2025Initiated Coverage$25.50$48.00Overweight$0.0000.00% ROIRAPTRapt Therapeutics10/13/2025Initiated Coverage$26.35$35.00Overweight$0.0000.00% ROITVRDTvardi Therapeutics10/13/2025Initiated Coverage$6.69$61.00Overweight$0.0000.00% ROIMRUSMerus9/30/2025Reiterated Rating$93.67$97.00Equal Weight$0.0000.00% ROIMRUSMerus9/30/2025Downgrade$94.15$97.00Equal Weight$0.0000.00% ROISRRKScholar Rock9/24/2025Lower Price Target$33.75$44.00Overweight$0.0000.00% ROICCCCC4 Therapeutics9/22/2025Boost Price Target$3.16$10.00Overweight$0.0000.00% ROIXNCRXencor9/17/2025Initiated Coverage$8.62$6.00Underweight$0.0000.00% ROIMGNXMacroGenics9/17/2025Initiated Coverage$1.47$3.00Overweight$0.0000.00% ROIEXELExelixis9/17/2025Initiated Coverage$39.14$40.00Equal Weight$0.0000.00% ROICTMXCytomX Therapeutics9/17/2025Initiated Coverage$1.96$3.50Overweight$0.0000.00% ROIARVNArvinas9/17/2025Initiated Coverage$7.64$16.00Overweight$0.0000.00% ROITERNTerns Pharmaceuticals9/17/2025Initiated Coverage$7.30$15.00Overweight$0.0000.00% ROISMMTSummit Therapeutics9/17/2025Initiated Coverage$18.12$13.00Underweight$0.0000.00% ROISRRKScholar Rock9/17/2025Initiated Coverage$32.34$45.00Overweight$0.0000.00% ROIPTGXProtagonist Therapeutics9/17/2025Initiated Coverage$58.59$72.00Overweight$0.0000.00% ROIMRUSMerus9/17/2025Initiated Coverage$66.90$112.00Overweight$0.0000.00% ROIKYMRKymera Therapeutics9/17/2025Initiated Coverage$48.78$60.00Overweight$0.0000.00% ROIJANXJanux Therapeutics9/17/2025Initiated Coverage$23.41$47.00Overweight$0.0000.00% ROICCCCC4 Therapeutics9/17/2025Initiated Coverage$3.41$8.00Overweight$0.0000.00% ROIARVNArvinas9/16/2025Upgrade$7.61Strong-Buy$0.0000.00% ROICCCCC4 Therapeutics9/16/2025Initiated Coverage$3.38$8.00Overweight$0.0000.00% ROICTMXCytomX Therapeutics9/16/2025Upgrade$1.93Strong-Buy$0.0000.00% ROIEXELExelixis9/16/2025Upgrade$40.44Hold$0.0000.00% ROIJANXJanux Therapeutics9/16/2025Initiated Coverage$23.46$47.00Overweight$0.0000.00% ROIKYMRKymera Therapeutics9/16/2025Initiated Coverage$48.12$60.00Overweight$0.0000.00% ROIMGNXMacroGenics9/16/2025Upgrade$1.53Strong-Buy$0.0000.00% ROIMRUSMerus9/16/2025Initiated Coverage$68.18$112.00Overweight$0.0000.00% ROIPTGXProtagonist Therapeutics9/16/2025Initiated Coverage$59.22$72.00Overweight$0.0000.00% ROISMMTSummit Therapeutics9/16/2025Initiated Coverage$18.09$13.00Underweight$0.0000.00% ROISRRKScholar Rock9/16/2025Initiated Coverage$31.95$45.00Overweight$0.0000.00% ROITERNTerns Pharmaceuticals9/16/2025Initiated Coverage$7.40$15.00Overweight$0.0000.00% ROIXNCRXencor9/16/2025Upgrade$9.25Strong Sell$0.0000.00% ROIIVAInventiva9/2/2025Boost Price Target$6.19$13.00Buy$0.0000.00% ROISRRKScholar Rock8/7/2025Lower Price Target$34.62$45.00Outperform$0.0000.00% ROIThe REAL Reason Trump is Invading Iran (Ad)For a moment… Forget about Trump’s ties to Israel. Forget about reports of Iran’s nuclear program. Because my research has led me to believe we’re risking World War 3 with Iran for a completely different reason.Click here to find out what it is.TERNTerns Pharmaceuticals5/13/2025Lower Price Target$2.93$15.00Outperform$0.0000.00% ROIVERVVerve Therapeutics4/15/2025Boost Price Target$5.07$24.00Buy$0.0000.00% ROIIVAInventiva4/4/2025Lower Price Target$3.26$9.00Buy$0.0000.00% ROIARVNArvinas3/12/2025Set Price Target$8.51$20.00Outperform$00.0000.00% ROIBNTXBioNTech3/11/2025Boost Price Target$105.35$143.00Outperform$00.0000.00% ROIARVNArvinas2/12/2025Reiterated Rating$18.88$82.00Outperform$00.0000.00% ROI Stock Forecasts and Research Tools Today's Analyst Ratings U.S. Ratings U.K. Ratings Canadian Ratings All Upgrades All Downgrades All Initiations All Price Target Changes Top-Rated Stocks Top Rated Stocks Top-Rated Dividend Stocks Top-Rated Small-Cap Stocks Top-Rated Tech Stocks Most-Upgraded Stocks Most-Downgraded Stocks Lowest-Rated Stocks More Ratings Tools Stock Ratings by Issuer Top-Rated Analysts Top-Rated Brokerages Stock Ratings Screener Free Ratings Newsletter Price Forecasts for Popular Stocks Alphabet (Google) Stock ForecastAmazon Stock ForecastApple Stock ForecastMeta (Facebook) Stock ForecastMicrosoft Stock ForecastNetflix Stock ForecastNvidia Stock ForecastTesla Stock Forecast Top Stock Recommendations by BrokerageWall Street ZenUBS GroupCitigroupBarclaysRoyal Bank Of CanadaMorgan StanleyWells Fargo & CompanyJPMorgan Chase & Co.Jefferies Financial GroupThe Goldman Sachs GroupTD CowenTruist FinancialPiper SandlerBMO Capital MarketsDeutsche Bank Aktiengesellschaft Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
